Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
2.210
+0.140 (6.76%)
May 14, 2025, 9:42 AM - Market open
Ensysce Biosciences Employees
As of December 31, 2024, Ensysce Biosciences had 8 total employees, including 7 full-time and 1 part-time employees. The number of employees increased by 1 or 14.29% compared to the previous year.
Employees
8
Change (1Y)
1
Growth (1Y)
14.29%
Revenue / Employee
$651,254
Profits / Employee
-$998,403
Market Cap
3.11M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8 | 1 | 14.29% |
| Dec 31, 2023 | 7 | 0 | - |
| Dec 31, 2022 | 7 | 1 | 16.67% |
| Dec 31, 2021 | 6 | 3 | 100.00% |
| Dec 31, 2020 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ENSC News
- 17 hours ago - Ensysce Biosciences Reports First Quarter 2025 Financial Results - Accesswire
- 2 days ago - Ensysce Biosciences Bolsters Management Team with Regulatory Expert - Accesswire
- 19 days ago - Ensysce Biosciences, Inc. Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds - Accesswire
- 20 days ago - Ensysce Biosciences Stock Doubles In One Trading Session - Here's Why - Benzinga
- 20 days ago - Ensysce Biosciences, Inc. Announces Exercise of Warrants for $2.2 Million Gross Proceeds - Accesswire
- 21 days ago - Ensysce Biosciences Receives U.S. Patent for Groundbreaking Treatment of Opioid Use Disorder - Accesswire
- 4 weeks ago - Ensysce Biosciences Announces Positive Data from Opioid Overdose Protection Study - Accesswire
- 6 weeks ago - Ensysce Biosciences, Inc. Announces $1.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Accesswire